GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,398,000 | +86.9% | 20,528 | -12.3% | 0.09% | +127.5% |
| Q2 2022 | $748,000 | +10.3% | 23,397 | +19.5% | 0.04% | +11.1% |
| Q1 2022 | $678,000 | -4.2% | 19,585 | -19.0% | 0.04% | -16.3% |
| Q4 2021 | $708,000 | +185.5% | 24,183 | +148.7% | 0.04% | +207.1% |
| Q3 2021 | $248,000 | -61.2% | 9,725 | -46.7% | 0.01% | -58.8% |
| Q2 2021 | $639,000 | -0.8% | 18,237 | +15.4% | 0.03% | -8.1% |
| Q1 2021 | $644,000 | -37.7% | 15,803 | -15.7% | 0.04% | +8.8% |
| Q3 2020 | $1,034,000 | – | 18,750 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |